TP53 and cancer: The enriched KEGG pathways (Figure 4B) included the following: pathways in cancer; the p53 signaling pathway; the cell cycle; apoptosis; the MAPK (Mitogen Activated Protein Kinase) signaling pathway; the TLR (Toll Like Recepter) signaling pathway; and focal adhesion.